A federal grand jury in the Middle District of Florida returned an indictment Wednesday charging a U.K. citizen for his role in a conspiracy to submit fraudulent claims for telehealth services associated with prescriptions for genetic testing and for causing the submission of false Medicare enrollment documents.
According to the indictment, Marek Rex Vernon Harrison, 61, a U.K. citizen living in Plant City, Florida, was the true beneficial owner and manager of purported telemedicine company CTD Network LLC (CTD). As alleged, CTD employed medical providers to authorize prescriptions for genetic tests, including tests designed to assess cancer risk. The providers conducted purported telehealth consultations in which they approved genetic-testing orders for Medicare beneficiaries referred by marketing companies or laboratories, even though the providers had no prior relationship with the beneficiaries and did not treat them or use the test results for treatment. At Harrison’s direction, CTD allegedly billed Medicare for these telehealth services, which were medically unnecessary and/or not provided as billed. In total, CTD submitted more than $2.7 million in false and fraudulent claims for telehealth services to Medicare, and Medicare paid over $600,000 on those claims.
As further alleged, part of the scheme involved falsifying Medicare enrollment documents submitted to the Centers for Medicare and Medicaid Services (CMS) to conceal Harrison’s role in CTD. CMS requires submitting entities to disclose all persons with a 5% or greater ownership interest or managing control, and to identify whether such individuals have been the subject of a final adverse legal action. At Harrison’s direction, CTD allegedly submitted Medicare enrollment forms falsely listing other individuals as owners and/or managers and concealing Harrison’s 2019 bank fraud conviction.
Acting Assistant Attorney General Matthew R. Galeotti of the Justice Department’s Criminal Division; U.S. Attorney Gregory W. Kehoe for the Middle District of Florida; Special Agent in Charge Matthew Fodor of the FBI’s Tampa Field Office; Special Agent in Charge Douglas DePodesta of the FBI’s Chicago Field Office; and Deputy Inspector General for Investigations Christian J. Schrank of the U.S. Department of Health and Human Services, Office of Inspector General (HHS-OIG) made the announcement.
FBI and HHS-OIG are investigating the case.
Acting Assistant Chief Catherine Wagner and Trial Attorney Miriam Glaser Dauermann of the Justice Department’s Fraud Section are prosecuting the case.